| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 21, 2007
Revised on July 11, 2007
Accepted on July 18, 2007
From the Oates Institute for Experimental Therapeutics and Division of Clinical Pharmacology, Departments of Medicine and Pharmacology (N.C., T.Y., I.H., B.C.K.); and Department of Pediatrics (P.J.K.), Vanderbilt University Medical Center, Nashville, Tenn; Cardiovascular Research Institute (T.H.), Washington Hospital Center, Washington DC; Laboratory for Mammalian Genes and Development (K.E., K.P.), National Institute of Child Health and Human Development/NIH, Bethesda, Md; Department of Medicine (B.A., L.R.J.), Krannert Institute of Cardiology, Indianapolis, Ind; and Department of Cell and Developmental Biology (C.F.-A.), University of Pennsylvania, Philadelphia.
* To whom correspondence should be addressed. E-mail: bjorn.knollmann{at}vanderbilt.edu.
Cardiac calsequestrin–null mice (Casq2-/-) display catecholaminergic ventricular tachycardia akin to humans with CASQ2 mutations. However, the specific contribution of Casq2 deficiency to the arrhythmia phenotype is difficult to assess because Casq2-/- mice also show significant reductions in the sarcoplasmic reticulum (SR) proteins junctin and triadin-1 and increased SR volume. Furthermore, it remains unknown whether Casq2 regulates SR Ca2+ release directly or indirectly by buffering SR luminal Ca2+. To address both questions, we examined heterozygous (Casq2+/-) mice, which have a 25% reduction in Casq2 but no significant decrease in other SR proteins. Casq2+/- mice (n=35) challenged with isoproterenol displayed 3-fold higher rates of ventricular ectopy than Casq2+/+ mice (n=31; P<0.05). Programmed stimulation induced significantly more ventricular tachycardia in Casq2+/- mice than in Casq2+/+ mice. Field-stimulated Ca2+ transients, cell shortening, L-type Ca2+ current, and SR volume were not significantly different in Casq2+/- and Casq2+/+ myocytes. However, in the presence of isoproterenol, SR Ca2+ leak was significantly increased in Casq2+/- myocytes (Casq2+/- 0.18±0.02 Fratio versus Casq2+/+ 0.11±0.01 Fratio, n=57, 60; P<0.01), resulting in a significantly higher rate of spontaneous SR Ca2+ releases and triggered beats. SR luminal Ca2+ measured using Mag-Fura-2 was not altered by Casq2 reduction. As a result, the relationship between SR Ca2+ leak and SR luminal Ca2+ was significantly different between Casq2+/- and Casq2+/+ myocytes (P<0.01). Thus, even modest reductions in Casq2 increase SR Ca2+ leak and cause ventricular tachycardia susceptibility under stress. The underlying mechanism is likely the direct regulation of SR Ca2+ release channels by Casq2 rather than altered luminal Ca2+.
Related Article:
This article has been cited by other articles:
![]() |
D. H. MacLennan and S. R. W. Chen Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes J. Physiol., July 1, 2009; 587(13): 3113 - 3115. [Full Text] [PDF] |
||||
![]() |
L. Royer and E. Ríos Deconstructing calsequestrin. Complex buffering in the calcium store of skeletal muscle J. Physiol., July 1, 2009; 587(13): 3101 - 3111. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.ör. C. Knollmann New roles of calsequestrin and triadin in cardiac muscle J. Physiol., July 1, 2009; 587(13): 3081 - 3087. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chopra, T. Yang, P. Asghari, E. D. Moore, S. Huke, B. Akin, R. A. Cattolica, C. F. Perez, T. Hlaing, B. E. C. Knollmann-Ritschel, et al. Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias PNAS, May 5, 2009; 106(18): 7636 - 7641. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yuan, P. Han, M. Dong, X. Ren, X. Zhou, S. Chen, W. K. Jones, G. Chu, H.-S. Wang, and E. G. Kranias Partial downregulation of junctin enhances cardiac calcium cycling without eliciting ventricular arrhythmias in mice Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1484 - H1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kasneci, N. M. Kemeny-Suss, S. V. Komarova, and L. E. Chalifour Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells Cardiovasc Res, March 1, 2009; 81(4): 695 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Murphy, N. T. Larkins, J. P. Mollica, N. A. Beard, and G. D. Lamb Calsequestrin content and SERCA determine normal and maximal Ca2+ storage levels in sarcoplasmic reticulum of fast- and slow-twitch fibres of rat J. Physiol., January 15, 2009; 587(2): 443 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chopra, D. Laver, S. S. Davies, and B. C. Knollmann Amitriptyline Activates Cardiac Ryanodine Channels and Causes Spontaneous Sarcoplasmic Reticulum Calcium Release Mol. Pharmacol., January 1, 2009; 75(1): 183 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cheng and W. J. Lederer Calcium Sparks Physiol Rev, October 1, 2008; 88(4): 1491 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rizzi, N. Liu, C. Napolitano, A. Nori, F. Turcato, B. Colombi, S. Bicciato, D. Arcelli, A. Spedito, M. Scelsi, et al. Unexpected Structural and Functional Consequences of the R33Q Homozygous Mutation in Cardiac Calsequestrin: A Complex Arrhythmogenic Cascade in a Knock In Mouse Model Circ. Res., August 1, 2008; 103(3): 298 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Yeh, R. Wakili, X.-Y. Qi, D. Chartier, P. Boknik, S. Kaab, U. Ravens, P. Coutu, D. Dobrev, and S. Nattel Calcium-Handling Abnormalities Underlying Atrial Arrhythmogenesis and Contractile Dysfunction in Dogs With Congestive Heart Failure Circ Arrhythm Electrophysiol, June 1, 2008; 1(2): 93 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Shannon Linking Calsequestrin to Lumenal Control of SR Ca2+ Release Circ. Res., September 14, 2007; 101(6): 539 - 541. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |